Robinson Lab

Main Research Focus:

Molecular Biology of Melanoma

Lab personnel:

Willaim A. Robinson, MD, PhD - PI
Carol Amato MS  PRA
Steven Robinson PRA

Recent Publications:

Bemis,L.T., Chen,R., Amato,C.M., Robinson,S.E., Classen,E.H., Coffey,D.G., Erickson,P.F. and Robinson,W.A.  microRNA-137 Targets Microphthalmia-associated Transcription Factor (MITF) Expression in Melanoma Cell Lines.  Cancer Res. 2008;68(5):1362-8.

Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA. Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate.  J Cutan Pathol. 2008 Feb;35(2):197-202.

Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA Merkel cell carcinoma: Evaluation of KIT expression. J of Cutaneous Path 34:324-27. 2007

High WA, Robinson WA.Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol.;23:61-79. 2007

Lewis KD, Robinson WA, Millward MJ, et al A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs. 2007 [Epub ahead of print]

Bemis LT, Robinson WA, McFarlane R, et al .EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Lancet Oncol.;8:559-60. 2007